$200 or $150? Nvidia’s February 25 Earnings Will Settle the Debate
Nvidia (NASDAQ:NVDA) sits at $188.52 after a 6% weekly surge. Prediction markets assign just 6% odds the stock hits $200 by month-end, yet analyst consensus targets $253. Someone’s badly wrong.
The Bull Case: Infrastructure Cycle Just Starting
Jensen Huang laid out the path on the Q3 earnings call: “I believe that there will be no digestion until we modernize a trillion dollars with the data centers.
» Read more about: $200 or $150? Nvidia’s February 25 Earnings Will Settle the Debate »
Read MoreAI Stocks Pick Up Steam—and the Nasdaq Tests Records—Ahead of Big Tech Earnings
Key Takeaways
- The Nasdaq Composite approached a fresh record high Wednesday as semiconductor stocks rallied following strong results from chip manufacturing equipment supplier ASML Holdings.
- The Nasdaq last closed at a record in late October, right before Big Tech earnings reports fueled debate on Wall Street about an AI bubble.
» Read more about: AI Stocks Pick Up Steam—and the Nasdaq Tests Records—Ahead of Big Tech Earnings »
Read MoreBig Tech Earnings Live: Meta and Tesla Shares Surge on Strong Results; Microsoft Drops Despite Beating Estimates
January 28, 2026 05:34 PM EST
Backlog Concentration, Cloud Growth Weigh on Microsoft
FROM 54 minutes ago
Jefferies analyst Brent Thill said the decline in Microsoft stock is likely due to Azure’s cloud platform revenue growth slowing and coming close to just in line with estimates,
US Fed holds interest rates and defends independence
Two Fed officials voted in favour of an interest rate cut – Stephen Miran, who is on leave from his post at the White House where he leads Trump’s Council of Economic Advisers, and Christopher Waller, a Trump appointee whose name has been floated as contender to succeed Powell.
» Read more about: US Fed holds interest rates and defends independence »
Read More3 Reasons ASML Stock Could Soar in 2026
Key Points
-
ASML’s growth accelerated in 2025 as its orders soared.
-
The growing AI and memory chip markets are fueling that expansion.
» Read more about: 3 Reasons ASML Stock Could Soar in 2026 »
Read MoreThe Burst
UnitedHealth Could Get Worse Before It Gets Better
After a punishing first half of the year, UnitedHealth’s latest earnings report delivered another gut punch.
The stock, which had already been cut in half year-to-date by July 31, slid even further following the release.
Between deteriorating fundamentals, mounting regulatory pressure, and a brutal earnings revision, it’s fair to ask whether UnitedHealth finally hit bottom,
» Read more about: UnitedHealth Could Get Worse Before It Gets Better »
Read MoreThe Ivy
1 Solar Sleeper Stock That Still Has Room to Shine
When Nextracker went public two years ago, few investors expected it to triple so quickly.
But after such a run, is it too late to buy? Or is this “picks and shovels” play on the clean-energy revolution still undervalued?
Key Points
-
Nextracker controls about a quarter of the global solar tracker market.
» Read more about: 1 Solar Sleeper Stock That Still Has Room to Shine »
Read MoreThe Spotlight
3 Safe-Haven Stocks to Buy Now as the Market Sells Off
With the S&P 500 now in correction and stocks selling off quickly, investors are understandably looking for safe-haven stocks to preserve their capital and keep their portfolios guarded from potentially turbulent market conditions ahead.
Luckily, there are still several companies that could offer some degree of security. Among the safest stocks to buy now for both current security and potential long-term returns are Abbott Labs,
» Read more about: 3 Safe-Haven Stocks to Buy Now as the Market Sells Off »